Please provide your email address to receive an email when new articles are posted on . LOS ANGELES — Treatment with cannabidiol led to improved seizure and nonseizure outcomes in patients with ...
Among Dravet syndrome patients in the SKYLINE trial, the median change from baseline in convulsive seizure frequency over the full treatment period was -22.16% with soticlestat and -8.64% with placebo ...
PHOENIX — Valley doctors will now be able to identify non-convulsive seizures due to new technology powered by artificial intelligence, according to a press release. Abrazo Arrowhead Campus in ...
MedPage Today on MSN
Study Suggests Concerning Connections Between Seizures and Heart Disease
"Our findings highlight the interconnectedness of heart and vascular health with brain health in middle-aged and older adults ...
Epilepsy is one of the most common neurological disorders, affecting 3.4 million Americans or 1 in 26 over a lifetime. The hallmark of epilepsy is seizures caused by abnormal bursts of electrical ...
SRF (SYNGAP1), RSRT (Rett), CACNA1A, STXBP1, Loulou (CDKL5), & KCNQ2 Cure (KCNQ2) collaborate to support Dr. Devinsky’s research for clinical trial readiness. Co-funded by multiple organizations, this ...
BEDFORD, Mass.--(BUSINESS WIRE)--Stoke Therapeutics, Inc. (Nasdaq: STOK), a biotechnology company dedicated to restoring protein expression by harnessing the body’s potential with RNA medicine, today ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback